A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19
Clinical trial NCT05758519 · UNKNOWN
Trial details
- NCT number
- NCT05758519
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2023-06-30
- Enrollment
- 1220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.